In the present study, we found that lower expression of GALNT14 was associated with a worse PFS, implying that GALNT14 may play a tumor suppressor role in HCC, but the molecular mechanisms of GALNT14 in predicting survival of HCC patients need to be further investigated. The gene discussed is GALNT14; the disease is hepatocellular carcinoma.